First Time Loading...

Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 3.35 USD 1.52% Market Closed
Updated: May 3, 2024

Repare Therapeutics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repare Therapeutics Inc
Operating Income Peer Comparison

Comparables:
ZYME
TH
FUSN
AUPH
EDT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Income
-$116.2m
CAGR 3-Years
-30%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Operating Income
-$138.1m
CAGR 3-Years
10%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Income
-$7.5m
CAGR 3-Years
27%
CAGR 5-Years
-30%
CAGR 10-Years
2%
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Operating Income
-$99.2m
CAGR 3-Years
-38%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Income
-$91.7m
CAGR 3-Years
4%
CAGR 5-Years
-10%
CAGR 10-Years
-36%
Spectral Medical Inc
TSX:EDT
Operating Income
-CA$11.7m
CAGR 3-Years
-9%
CAGR 5-Years
-38%
CAGR 10-Years
0%

See Also

What is Repare Therapeutics Inc's Operating Income?
Operating Income
-116.2m USD

Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Operating Income amounts to -116.2m USD.

What is Repare Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-55%

Over the last year, the Operating Income growth was -487%. The average annual Operating Income growth rates for Repare Therapeutics Inc have been -30% over the past three years , -55% over the past five years .